SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Mahboubi E, Kemet J, Cook PJ, Day NE, Ghadirian P, Salmasizadeh S. Oesophageal cancer studies in the Caspian littoral of Iran: The Caspian Cancer Registry. Br J Cancer 1973;28: 197214.
  • 2
    Habibi A. Cancer in Iran. A survey of the most common cases. J Natl Cancer Inst 1965;34: 55369.
  • 3
    Nadim A, Nourai M. Cancers. In: AziziF, HatamiH, JanghorbaniM, eds. Epidemiology and control of common diseases in Iran, 1st ed. Tehran: Eshtiagh, 2000. 2167.
  • 4
    Haghighi P, Nasar K. Gastrointestinal cancer in Iran. J Chronic Dis 1971;24: 62533.
  • 5
    Saalabian MJ. Registry of neoplastic diseases. Shiraz University of Medical Sciences, Medical School and Iranian Cancer Society, Fars Province. 1982–89 Report.
  • 6
    Joint Iran and IARC study group. Esophageal cancer studies in the Caspian littoral of Iran: results of population studies: a prodrome. J Natl Cancer Inst 1977;54: 112738.
  • 7
    Kemet J, Mahboubi E. Esophageal cancer in the Caspian littoral of Iran: initial studies. Science 1972;175: 84653.
  • 8
    Aramesh B, Salmasizadeh S. Epidemiologic and laboratory study of malignant tumours in Caspian littoral. Iran Health J 1975;4: 116.
  • 9
    Cook-Mozaffari PJ, Azordegan F, Day NE, Ressicaud A, Sabai C, Aramesh B. Esophageal cancer studies in the Caspian littoral of Iran: results of a case-control study Br J Cancer 1979;39: 293309.
  • 10
    Ghadirian P, Stein GF, Gorodetzky C, Roberfroid MB, Mahon GAT, Bartsch H, Day NE. Oesophageal cancer studies in the Caspian littoral of Iran: some residual results including opium use as a risk factor. Int J Cancer 1985;35: 5937.
  • 11
    Naghavi M. Death report from 10 provinces in Iran, 1st ed. Tehran: Ministry of Health, 2000.
  • 12
    Mosavi-Jarrahi A, Mohagheghi MA, Zeraatti H, Mortazavi H. Cancer registration in Iran. Asian Pac J Cancer Prev 2001;2: 259.
  • 13
    Saidi F, Sepehr A, Fahimi S, Farahvash MJ, Salehian P, Esmailzadeh A, Keshoofy M, Pirmoazen N, Yazdanbod M, Roshan MK. Oesophageal cancer among the Turkomans of northeast Iran. Br J Cancer 2000;83: 124954.
  • 14
    Statistical Center of Iran. Iran statistic yearbook. Tehran: Statistical Center of Iran, 1999. 546.
  • 15
    Fritz PA, Percy C, Jack A, Shanmugaratnuers K, Solin L, Parkin DM, Whelan S. International classification of diseases for oncology, 3rd ed. Geneva: WHO, 2000.
  • 16
    Jensen OM, Parkin DM, Maclennau R, Mair CS, Skeet RG. Cancer registration: principles and methods, 1st ed. Lyon: IARC, 1991.
  • 17
    Haghighi P, Nabizadeh I, Asvadi S, Mohallatee EA. Cancer in southern Iran. Cancer 1971;27: 96577.
  • 18
    Yazdanbod A, Derakhshan MH, Arshi S, Sadjadi AR, Malekzadeh R. Gastric cardia cancer; the most common type of upper gastrointestinal cancer in Ardabil, Iran: an endoscopy clinic experience. Arch Iranian Med 2001;4: 769.
  • 19
    Mikaeli J, Malekzadeh R, Ziad-Alizadeh B, Nasseri-Mogaddam S, Valizadeh M, Khoncheh R, Massarrat S. Prevalence of Helicobacter pylori in two Iranian provinces with high and low incidence of gastric carcinoma. Arch Iranian Med 2000;3: 69.
  • 20
    Saidi F, Malekzadeh R, Sotoudeh M, Derakhshan MH, Farahvash MJ, Yanzdanbod A, Merat S, Mikaeli J, Sotoudehmanesh R, Nasseri-Moghadam S, Majidpour A, Arshi S, et al. An endoscopic esophageal cancer survey of Ardabile in the northwest Iran. Dis Esophagus 2002;15: 2148.
  • 21
    Wallerstein C. Costa Rica tackles high rates of stomach cancer. BMJ 2001;323: 1270.
  • 22
    Ferlay J, Bray B, Pisani P, Parkin DM. Globocan 2000. Cancer incidence, mortality and prevalence worldwide. Lyon: IARC, 2001.
  • 23
    Draini PK, Holmes KK, Hughes JP, Koutsky LA. Determinants of cervical cancer rates in developing countries. Int J Cancer 2002;100: 199205.
  • 24
    Parkin DM. Cancer occurrence in developing countries. Lyon: IARC, 1986. 2318.